Stocks · Health care · Pharmaceutical Preparations

Amylyx Pharmaceuticals, Inc.

AMLX Clue Score40
United States Fiscal year ends December CIK 0001658551 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
George M Milne Jr
5 Oct 2026
Director
Sold on a plan
30,000
$27.70
$830.90K
Gina Mazzariello
10 Jul 2026
Chief Legal Officer
Sold on a plan
15,000
$17.61
$264.12K
Gina Mazzariello
9 Jul 2026
Chief Legal Officer
Sold on a plan
15,000
$18.32
$274.75K

What was left out

Form 4 filings counted 42
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 4
Sales at will 24
Transactions with no price 0
Shares from compensation/vesting 1,419,126
History held since 10 Jan 2022